Document:

EX-10.19

 Exhibit 10.19 

Adopted November 1, 2018 

VINEBROOK HOMES TRUST, INC. 

Share Repurchase Plan 
 Effective as
of November 1, 2018 
 Definitions 
 Board
— shall mean the board of directors of the Company. 
 Class A shares — shall mean the shares of the Company’s
common stock classified as Class A. 
 Class I shares — shall mean the shares of the Company’s common stock
classified as Class I. 
 Company — shall mean VineBrook Homes Trust, Inc., a Maryland corporation. 

NAV — shall mean the net asset value of the Company or a class of its shares, as the context requires, determined in accordance with the
Company’s valuation policies and procedures. 
 Offering — shall mean the initial offering of Class A shares pursuant to that
certain confidential private placement memorandum, dated August 28, 2018. 
 Operating Partnership — shall mean VineBrook Homes
Operating Partnership, L.P. 
 Stockholders — shall mean the holders of Class A shares or Class I shares. 

Transaction Price — shall mean the repurchase price per share for each class of common stock, which shall be equal to the then-current offering
price before applicable selling commissions and dealer manager fees. 
 Share Repurchase Plan 

Stockholders may request that the Company repurchase shares of its common stock through their financial advisor or directly with the Company’s transfer
agent. The procedures relating to the repurchase of shares of the Company’s common stock are as follows: 
  

	 	•	 	 Under this share repurchase plan, to the extent the Company chooses to repurchase shares in any particular
quarter, the Company will only repurchase shares as of the last calendar day of that quarter (a “Repurchase Date”). To have shares repurchased, a Stockholder’s repurchase request and required documentation must be received in good
order by 4:00 p.m. (Eastern time) on the business day before the Repurchase Date. Settlements of share repurchases will be made within three business days of the Repurchase Date. The Company will begin this share repurchase plan on November 1,
2019. However, Stockholders may be assessed an Early Sales Fee of 5.0% for any shares repurchased after November 1, 2019 but prior to November 1, 2020. Repurchase requests received and processed by the Company’s transfer agent will be
effected at a repurchase price equal to the Transaction Price on the applicable Repurchase Date (which will generally be equal to the Company’s prior quarter’s NAV per share). 

 

	 	•	 	 A Stockholder may withdraw his or her repurchase request by notifying the transfer agent, directly or through his
or her financial intermediary, on the Company’s toll-free, automated telephone customer service number at (844) 485-9167. The line is open on each business day between the hours of 9:00 a.m. and 6:00 p.m.
(Eastern time). Repurchase requests must be cancelled before 4:00 p.m. (Eastern time) on the applicable Repurchase Date (or if such Repurchase Date is not a business day, the prior business day). 

	 	•	 	 If a repurchase request is received after 4:00 p.m. (Eastern time) on the business day before the Repurchase
Date, the purchase order will be executed, if at all, on the next quarter’s Repurchase Date at the Transaction Price applicable to that quarter, unless such request is withdrawn prior to the repurchase. Repurchase requests received and
processed by the Company’s transfer agent on a business day, but after the close of business on that day or on a day that is not a business day, will be deemed received on the next business day. 

 

	 	•	 	 Repurchase requests may be made by mail or by contacting such Stockholder’s financial intermediary, both
subject to certain conditions described in this share repurchase plan. Written requests signed by the registered account owner should be sent to the Company’s transfer agent specifying (1) the Stockholder’s account number,
(2) the name or names registered on the account and (3) the dollar value or number of shares the Stockholder wishes to be repurchased. Written requests should be sent to the transfer agent at the following address: 

NexPoint/Highland 
 C/O
DST Systems 
 430 W. 7th Street 

Kansas City, MO 64105 

Corporate investors and other non-individual entities must have an appropriate certification on file
authorizing repurchases. A signature guarantee may be required. 
  

	 	•	 	 For processed repurchases, Stockholders may request that repurchase proceeds are to be paid by mailed check
provided that the amount is less than $100,000 and the check is mailed to an address on file with the transfer agent for at least 30 days. 

  

	 	•	 	 Processed repurchases of more than $100,000 will be paid only via wire transfer. For this reason, Stockholders
who own more than $100,000 of the Company’s common stock must provide wiring instructions for their brokerage account or designated U.S. bank account. Stockholders who own less than $100,000 of the Company’s common stock may also receive
repurchase proceeds via wire transfer, provided the payment amount is at least $2,500. For all repurchases paid via wire transfer, the funds will be wired to the account on file with the transfer agent or, upon instruction, to another financial
institution provided that the Stockholder has made the necessary funds transfer arrangements. The customer service representative can provide detailed instructions on establishing funding arrangements and designating a bank or brokerage account on
file. Funds will be wired only to U.S. financial institutions (ACH network members). 

  

	 	•	 	 A medallion signature guarantee will be required in certain circumstances. The medallion signature process
protects Stockholders by verifying the authenticity of a signature and limiting unauthorized fraudulent transactions. A medallion signature guarantee may be obtained from a domestic bank or trust company, broker-dealer, clearing agency, savings
association or other financial institution which participates in a medallion program recognized by the Securities Transfer Association. The three recognized 

	 	 
medallion programs are the Securities Transfer Agents Medallion Program, the Stock Exchanges Medallion Program and the New York Stock Exchange, Inc. Medallion Signature Program. Signature
guarantees from financial institutions which are not participating in any of these medallion programs will not be accepted. A notary public cannot provide signature guarantees. The Company reserves the right to amend, waive or discontinue this
policy at any time and establish other criteria for verifying the authenticity of any repurchase or transaction request. The Company may require a medallion signature guarantee if, among other reasons: (1) the amount of the repurchase request
is over $500,000; (2) a Stockholder wishes to have repurchase proceeds transferred by wire to an account other than the designated bank or brokerage account on file for at least 30 days or sent to an address other than such Stockholder’s
address of record for the past 30 days; or (3) the Company’s transfer agent cannot confirm a Stockholder’s identity or suspects fraudulent activity. 

 

	 	•	 	 If a Stockholder has made multiple purchases of shares of the Company’s common stock, any repurchase request
will be processed on a first in/first out basis unless otherwise requested in the repurchase request. 

 Minimum Account Repurchases

 In the event that any Stockholder fails to maintain the minimum balance of $10,000 of shares of the Company’s common stock, the Company may
repurchase all of the shares held by that Stockholder at the repurchase price in effect on the date the Company determines that such Stockholder failed to meet the minimum balance. Minimum account repurchases will apply even in the event that the
failure to meet the minimum balance is caused solely by a decline in the Company’s NAV. 
 Sources of Funds for Repurchases 

The Company may fund repurchase requests from sources other than cash flow from operations, including, without limitation, the sale of assets, borrowings,
return of capital or offering proceeds, and the Company has no limits on the amounts it may pay from such sources. 
 In an effort to have adequate cash
available to support this share repurchase plan, the Company may reserve borrowing capacity under a line of credit. The Company could then elect to borrow against this line of credit in part to repurchase shares presented for repurchase during
periods when it does not have sufficient proceeds from operating cash flows or the sale of shares in the Offering to fund all repurchase requests. If the Company determines to obtain a line of credit, the Company would expect that it would afford it
borrowing availability to fund repurchases. As the Company’s assets increase, however, it may not be commercially feasible or the Company may not be able to secure a line of credit of that size. Moreover, actual availability may be reduced at
any given time if the Company uses borrowings under the line of credit to fund repurchases or for other corporate purposes. 
 Repurchase Limitations

 The Company may repurchase fewer shares than have been requested in any particular quarter to be repurchased under this share repurchase plan, or
none at all, in the sole discretion of the Board at any time. In addition, the total amount of aggregate repurchases of shares will be limited to no more than 5% of the Company’s aggregate NAV per calendar quarter. 

 In the event that the Company determines to repurchase some but not all of the shares submitted for
repurchase during any quarter, shares submitted for repurchase during such quarter will be repurchased on a pro rata basis. All unsatisfied repurchase requests must be resubmitted after the start of the next quarter, or upon the recommencement of
this share repurchase plan, as applicable. 
 If the Transaction Price for the applicable quarter is not made available by the tenth business day prior to
the Repurchase Date (or is changed after such date), repurchases will be delayed until a NAV is made available. 
 Should repurchase requests, in the
Board’s judgment, place an undue burden on the Company’s liquidity, adversely affect the Company’s operations or risk having an adverse impact on the Company as a whole, or should the Board otherwise determine that investing the
Company’s liquid assets in the Operating Partnership rather than repurchasing shares is in the Company’s best interest as a whole, the Board may choose to repurchase fewer shares in any particular quarter than have been requested to be
repurchased, or none at all. Further, the Board may modify, suspend or terminate this share repurchase plan if it deems such action to be in the best interest of the Company and its Stockholders. Material modifications, including any amendment to
the 5% quarterly limitation on repurchases, to and suspensions of this share repurchase plan will be promptly disclosed to Stockholders in a special or periodic report. Material modifications will also be disclosed on the Company’s website. In
addition, the Company may determine to suspend this share repurchase plan due to regulatory changes, changes in law or if the Company becomes aware of undisclosed material information that it believes should be publicly disclosed before shares are
repurchased. Once this share repurchase plan is suspended, the Board must affirmatively authorize the recommencement of the plan before Stockholder requests will be considered again. 

Death and Disability Repurchases 
 The Company may
waive the Early Sales Fee with respect to the repurchase of shares resulting from the death of a Stockholder who is a natural person, subject to the conditions and limitations described in the “Share Repurchase Plan” section above,
including shares held by such Stockholder through a revocable grantor trust or an IRA or other retirement or profit-sharing plan, after receiving written notice from the estate of the Stockholder, the recipient of the shares through bequest or
inheritance, or, in the case of a revocable grantor trust, the trustee of such trust, who shall have the sole ability to request repurchase on behalf of the trust. The Company must receive the written repurchase request within 12 months after the
death of the Stockholder in order for the requesting party to rely on any of the special treatment that may be afforded in the event of the death of a Stockholder. Such a written request must be accompanied by a certified copy of the official death
certificate of the Stockholder. If spouses are joint registered holders of shares, the request to have shares repurchased may be made if either of the registered holders dies. If the Stockholder is not a natural person, such as certain trusts or a
partnership, corporation or other similar entity, the right of repurchase upon death does not apply. 
 Furthermore, the Company may waive the Early Sales
Fee with respect to the repurchase of shares held by a Stockholder who is a natural person who is deemed to have a qualifying disability (as such term is defined in Section 72(m)(7) of the Internal Revenue Code), subject to the conditions and
limitations described in the “Share Repurchase Plan” section above, including shares held by such Stockholder through a revocable grantor trust or an IRA or other retirement or profit-sharing plan, after receiving written notice from such
Stockholder, provided 

 
that the condition causing the qualifying disability was not pre-existing on the date that the Stockholder became a stockholder. The Company must receive
the written repurchase request within 12 months of the initial determination of the Stockholder’s qualifying disability in order for the Stockholder to rely on any of the waivers described above that may be granted in the event of the
qualifying disability of a Stockholder. If spouses are joint registered holders of shares, the request to have the shares repurchased may be made if either of the registered holders acquires a qualifying disability. If the Stockholder is not a
natural person, such as certain trusts or a partnership, corporation or other similar entity, the right of repurchase upon a qualifying disability does not apply. 

Other Repurchases 
 In the event the Company has
over 2,000 record holders of shares of common stock, or the Company believes it may go over 2,000 record holders, the Company may make tender offers or other repurchases to maintain a Stockholder base under 2,000 record holders as of the end of any
calendar year. 
 Items of Note 
 When a
Stockholder makes a request to have shares repurchased, such Stockholder should note the following: 
  

	 	•	 	 if a Stockholder is requesting that some but not all of its shares be repurchased, the Stockholder should keep
its balance above $10,000 to avoid minimum account repurchase, if applicable; 

  

	 	•	 	 a Stockholder will not receive interest on amounts represented by uncashed repurchase checks;

  

	 	•	 	 under applicable anti-money laundering regulations and other federal regulations, repurchase requests may be
suspended, restricted or cancelled and the proceeds may be withheld; and 

  

	 	•	 	 all shares requested to be repurchased must be beneficially owned by the Stockholder of record making the request
or his or her estate, heir or beneficiary, or the party requesting the repurchase must be authorized to do so by the Stockholder of record of the shares or his or her estate, heir or beneficiary, and such shares must be fully transferable and not
subject to any liens or encumbrances. In certain cases, the Company may ask the requesting party to provide evidence satisfactory to the Company that the shares requested for repurchase are not subject to any liens or encumbrances. If the Company
determines that a lien exists against the shares, the Company will not be obligated to repurchase any shares subject to the lien. 

 IRS
regulations require the Company to determine and disclose on Form 1099-B the adjusted cost basis for shares sold or repurchased. Although there are several available methods for determining the adjusted cost
basis, unless a Stockholder elects otherwise, which such Stockholder may do by checking the appropriate box on the subscription agreement or calling the Company’s customer service number at (844)
485-9167, the Company will utilize the first-in-first-out method. 

 Mail and Telephone Instructions 

The Company and its transfer agent will not be responsible for the authenticity of mail or phone instructions or losses, if any, resulting from unauthorized
Stockholder transactions if they reasonably believe that such instructions were genuine. The Company and its transfer agent have established reasonable procedures to confirm that instructions are genuine including requiring that Stockholders provide
certain specific identifying information on file and sending written confirmation to Stockholders of record no later than five days following execution of the instruction. Stockholders, or their designated custodian or fiduciary, should carefully
review such correspondence to ensure that the instructions were properly acted upon. If any discrepancies are noted, the Stockholder, or its agent, should contact his, her or its financial advisor as well as the Company’s transfer agent in a
timely manner, but in no event more than 60 days from receipt of such correspondence. Failure to notify such entities in a timely manner will relieve the Company, the Company’s transfer agent and the financial advisor of any liability with
respect to the discrepancy. 

			
	  
 VINEBROOK
HOMES TRUST, INC.
  
	  	  
 REPURCHASE AUTHORIZATION

 Use this form to request repurchase of your shares in VineBrook Homes Trust, Inc. (the “Company”). Please complete
all sections below. 
 1 REPURCHASE FROM THE FOLLOWING ACCOUNT 
  

			
	Name(s) on the Account
		
	Account Number	  	Social Security Number/TIN
		
	Financial Advisor Name	  	Financial Advisor Phone Number

  

			
	2 REPURCHASE AMOUNT (Check one)	  	3 REPURCHASE TYPE (Check one)
		
	 ☐ All Shares
 ☐ Number of
Shares
 ☐ Dollar Amount
	  	 ☐ Normal
 ☐ Death

☐ Disability

 Additional documentation is required if repurchasing due to Death or Disability. Contact Investor Relations
for detailed instructions at (844) 485-9167. 
 4 PAYMENT INSTRUCTIONS (Select only one) 

Indicate how you wish to receive your repurchase payment below. If an option is not selected, a check will be sent to your address of record. Repurchase
proceeds for qualified accounts, including IRAs and other Custodial accounts, and certain Broker-controlled accounts as required by your Broker/Dealer of record, will automatically be issued to the Custodian or Broker/Dealer of record, as
applicable. All Custodial held and Broker-controlled accounts must include the Custodian and/or Broker/Dealer signature. 
 ☐
Cash/Check Mailed to Address of Record 
 ☐ Cash/Check Mailed to Third Party/Custodian (Signature Guarantee required) 

 

			
	 Name / Entity Name / Financial Institution
	  	 Mailing Address

							
				
	 City
	 	 State
	 	 Zip Code
	 	 Account Number

 ☐ Cash/Direct Deposit Attach a pre-printed voided check. (Non-Custodian Investors Only) 
 I authorize the Company or its agent to deposit my distribution into my checking
or savings account. In the event that the Company deposits funds erroneously into my account, they are authorized to debit my account for an amount not to exceed the amount of the erroneous deposit. 

 

					
	 Financial Institution Name Mailing Address
	 	 City
	 	 State

		
	 Your Bank’s ABA Routing Number
	 	 Your Bank Account Number

 PLEASE ATTACH A
PRE-PRINTED VOIDED CHECK 

 5 SHARE REPURCHASE PLAN CONSIDERATIONS (Select only one) 

The share repurchase plan contains limitations on the number of shares that can be repurchased under the plan during any quarter. In addition to these
limitations, the Company cannot guarantee that it will have sufficient funds to accommodate all repurchase requests made in any applicable repurchase period and the Company may elect to repurchase fewer shares than have been requested in any
particular quarter, or none at all. If the number of shares subject to repurchase requests exceeds the then applicable limitations, or if the Company otherwise does not make all requested repurchases, each Stockholder’s request will be reduced
on a pro rata basis after the Company has repurchased all shares for which repurchase has been requested due to death or disability. If repurchase requests are reduced on a pro rata basis, you may elect (at the time of your repurchase request) to
either withdraw your entire request for repurchase or have your request honored on a pro-rata basis. If you wish to have the remainder of your initial request repurchased, you must resubmit a new repurchase
request for the remaining amount. Please select one of the following options below. If an option is not selected, your repurchase request will be processed on a pro-rata basis, if needed. 

☐ Process my repurchase request on a pro-rata basis. 

☐ Withdraw (do not process) my entire repurchase request if amount will be reduced on a pro-rata basis. 

6 COST BASIS SELECTION (Select only one) 
 U.S.
federal income tax information reporting rules generally apply to certain transactions in the Company’s shares. Where they apply, the “cost basis” calculated for the shares involved will be reported to the Internal Revenue Service
(“IRS”) and to you. Generally, these rules apply to the Company’s shares, including those purchased through the distribution reinvestment plan. You should consult your own tax advisor regarding the consequences of these new rules and
your cost basis reporting options. 
 Indicate below the cost basis method you would like the Company to apply. 

IMPORTANT: If an option is not selected, your cost basis will be calculated using the FIFO method. 

☐ FIFO (First In / First Out) 
 ☐ LIFO (Last In /
First Out) Consult your tax advisor to determine whether this method is available to you. 
 ☐ Specific Lots 

If you have selected “Specific Lots,” please identify the lots below: 
  

			
	 Date of Purchase:
	 	 Amount of Purchase:

		
	 Date of Purchase:
	 	 Amount of Purchase:

		
	 Date of Purchase:
	 	 Amount of Purchase:

 7 AUTHORIZATION AND SIGNATURE 

IMPORTANT: Signature Guarantee may be required if any of the following applies: 

 

	 	•	 	 Amount to be repurchased is $500,000 or more. 

 

	 	•	 	 The repurchase proceeds are to be sent to an address other than the address the Company has had on record for the
past 30 days. 

	 	•	 	 The repurchase proceeds are to be sent to an address other than the address on record. 

 

	 	•	 	 If the name has changed from the name in the account registration, the Company must have a one-and-the-same name signature guarantee. A one-and-the-same signature guarantee must state “<Previous Name> is
one-and-the-same as <New Name>“ and you must sign your old and new name. 

 

	 	•	 	 The repurchase proceeds are deposited directly according to banking instructions provided on this form. (Non-Custodial Investors Only) 

  

					
	Investor Name (Please Print)	  	Signature	  	Date
			
	Co-Investor Name (Please Print)	  	Signature	  	Date

			
		
	 Signature Guarantee

(Affix Medallion or Signature Guarantee Stamp Below)
	  	 Custodian and/or Broker/Dealer Authorization
(if applicable)

 
 Signature of Authorized Person

  

	*	 A copy of the share repurchase plan, as amended and supplemented to date, and the current repurchase price are
available on the following website http://www.vinebrookhomes.com/. There are various limitations on your ability to request that the Company repurchase your shares, including, subject to certain exceptions, a 5% quarterly limitation on repurchases
and an Early Sales Fee of 5.0% for any shares repurchased after the one-year anniversary date but prior to the two-year anniversary date of the initial closing of the
Offering. The Board may determine to modify, suspend or terminate the share repurchase plan without Stockholder approval. The Company will promptly disclose to you any material modifications, including any amendment to the 5% quarterly limitation on
repurchases, to and suspensions of the share repurchase plan in a special or periodic report. Material modifications will also be disclosed on the Company’s website. Repurchase of shares, when requested, will generally be made quarterly;
provided however, that the Board may determine from time to time to adjust the timing of repurchases. All requests for repurchases must be received in good order by 4:00 p.m. (Eastern time) on the business day before the Repurchase Date. A
Stockholder may withdraw his or her repurchase request by notifying the transfer agent, directly or through his or her financial intermediary, on the Company’s toll-free, automated telephone service number at (844) 485-9167. Repurchase requests must be cancelled before 4:00 p.m. (Eastern time) on the applicable Repurchase Date (or if such Repurchase Date is not a business day, the prior business day). The Company cannot
guarantee that it will have sufficient available funds or that it will otherwise be able to accommodate any or all requests made in any applicable repurchase period. 

 
  

Mail to: NexPoint/Highland | C/O DST Systems | 430 W. 7th Street | Kansas City, MO 64105 

Investor Relations: (844) 485-9167EX-10.1

 Exhibit 10.1 

CONSULTING AGREEMENT 

This Consulting Agreement (“Consulting Agreement”) is entered into as of July 22, 2021, by and between AlloVir, Inc., a
Delaware corporation with an address at 139 Main St., Suite 500 Cambridge, MA 02142 (the “Company”), and David Hallal (“Consultant”), effective as of the Effective Date (as defined below) except as otherwise
expressly provided below. 
 1. Consulting Services, Fees, Other Compensation and Expenses. During the Consulting Period, the Company hereby engages
Consultant and Consultant agrees to provide the Company the Services set for on Exhibit A (the “Services”) attached hereto and incorporated herein for all purposes. In exchange for the Services, the Company will
pay Consultant a fee of one hundred thousand dollars ($100,000), payable in four quarterly installments, in addition to reimbursable expenses as set forth on Exhibit A. Upon the termination of this Consulting Agreement in accordance
with Section 6.1 herein, the Company shall have no obligation to pay fees, commissions, or any other amounts under this Consulting Agreement for Services or expenses with respect to any period on or after the date of such termination. 

2. Consulting Period. Unless earlier terminated as provided for in Section 6, this Agreement is effective as of July 22, 2021 (the
“Effective Date”) and will continue through May 17, 2022 (such effective period of this Agreement, including any extensions to the initial term, the “Consulting Period”) and covers work performed by Consultant
for the Company in his capacity as Consultant. 
 3. Proprietary Information and Invention Assignment Agreement. Prior to any effectiveness of this
Agreement, Consultant shall execute and deliver to the Company a copy of the Proprietary Information and Invention Assignment Agreement in the form attached hereto as Exhibit B (the “Proprietary Agreement”). Consultant
further reaffirms his obligations under the Restrictive Covenants Agreement attached to his Employment Agreement dated October 2, 2019 as Exhibit A (the “Restrictive Covenants Agreement”), which remains in full force and
effect. Consultant agrees and understands that the restrictions in the Proprietary Agreement are in addition to the restrictions in the Restrictive Covenants Agreement. 

4. Conflicting Obligations. 
 4.1
Conflicts. Consultant agrees that he has not and will not enter into any agreement with a third party that is in conflict with any of the provisions of this Consulting Agreement or that would preclude Consultant from complying with the
provisions of this Consulting Agreement or any agreements provided for herein (including, without limitation, the Proprietary Agreement) during the Consulting Period. 

4.2 Separation. The Company acknowledges that the Consultant is the Chief Executive Officer of ElevateBio and a board member to
other entities and that the Consultant is subject to confidentiality agreements with those other entities. Consultant shall be responsible for ensuring his compliance with these agreements and any other limitations that may be imposed on Consultant.
Consultant shall use his best efforts to minimize or avoid any questions of disclosure 

  
 1 

 
of, or rights under, any inventions made by the Consultant in providing the Services to the Company (and to assist the Company and the Consultant’s other clients in fairly resolving any
questions which may arise). All Services and related documentation in connection with this Consulting Agreement shall be kept completely separate from the Consultant’s other activities in order to avoid any preemptions or overlap of other
rights or obligations of the Consultant. 
 5. Reports. Consultant will, from time to time during the Consulting Period, keep the Company advised as
to the progress in providing Services under this Consulting Agreement. 
 6. Termination of Consulting Agreement. 

6.1 Termination of Consulting Agreement. 

(a) This Consulting Agreement shall terminate upon the expiration of the Consulting Period. This Consulting Agreement may terminate earlier
upon any of the following: 
 (1) Ten (10) days’ notice to Consultant by the Company; 

(2) Assignment of the Agreement by Consultant without the Company’s consent; 

(3) Written notice to Consultant by the Company, effective immediately, of a Material Breach (as defined below) by Consultant;
or 
 (4) Ten (10) days’ notice to the Company by Consultant. 

(b) For purposes of this Agreement, “Material Breach” shall include failure or refusal to perform the Services; failure to
work cooperatively with Company staff; negligence or willful wrongdoing in the performance of Consultant’s duties’ Consultant’s material breach of any provision hereof or of the Proprietary Agreement; or failure to comply with
Section 8. 
 6.2 Survival. Upon such termination of this Consulting Agreement, all rights and duties of the Company and
Consultant toward each other shall cease except: 
 (a) The Company will pay, within thirty (30) days after the effective date of such
termination, all amounts owing to Consultant for Services completed and accepted by the Company prior to the termination date and related expenses, if any, submitted in accordance with the Company’s policies and in accordance with the
provisions of Exhibit A. Such payment shall constitute full settlement of any and all compensation due to Consultant; and 
 (b)
Section 3 (Proprietary Information and Invention Assignment Agreement), Section 4 (Conflicting Obligations), Section 7 (Independent Contractor; No Benefits), Section 8 (Indemnification), Section 10 (Arbitration and
Equitable Relief), and Exhibit B (Proprietary Agreement), will survive termination of this Consulting Agreement. 

  
 2 

 7. Independent Contractor; No Benefits. 

7.1 Independent Contractor. It is the express intention of the Company and Consultant that Consultant will provide the Services
as an independent contractor to the Company. Nothing in this Consulting Agreement shall in any way be construed to constitute Consultant and/or any of its Representatives as an agent, employee or representative of the Company during the Consulting
Period. Without limiting the generality of the foregoing, during the Consulting Period, Consultant is not authorized to bind the Company to any liability or obligation or to represent that it has any such authority except where expressly delegated
by the Company’s authorized representatives. Consultant is obligated to report as income all fees and other compensation received pursuant to this Consulting Agreement. Further, Consultant acknowledges the obligation to pay all, as the case may
be, self-employment and other taxes on such income. 
 7.1 No Benefits. During the Consulting Period, Consultant will
not receive any Company sponsored benefits that the Company may make available to its employees, including, but not limited to, group health or life insurance, profit-sharing or retirement bene fits. If Consultant were to be reclassified by a state
or federal agency or court as Company’s employee under the Internal Revenue Code of 1986, as amended, or otherwise with respect to the provision of Services hereunder , Consultant will not be eligible to receive any employee benefits from the
Company, except those mandated by state or federal law, even if by the terms of the Company’s benefit plans or programs in effect at the time of such reclassification, such employees or representatives would otherwise be eligible for such
benefits. 
 7.2 Taxes; Workers’ Compensation and Other Benefits. The Company will not withhold any taxes from payments
made to Consultant related to the Services and will report gross fees related to the Services, to the extent required by law, on an IRS Form 1099. Consultant is also solely responsible for the payment of all federal, state, local, or other
applicable taxes, income or otherwise, incurred or due as a result of the receipt of gross fees for Services hereunder, and Consultant will file, on a timely basis, all tax returns required to be filed by any federal, state, or local tax authority
with respect to the receipt of gross fees for Services hereunder. Consultant shall make such payments referred to in this paragraph as are required by law. 

8. Representations. 
 8.1 Each
party represents that this Consulting Agreement shall, when duly executed and delivered, constitute the legal, valid and binding obligation of each party, as applicable, enforceable in accordance with its terms. Each party further represents and
warrants that: (i) it has all rights necessary to enter into and perform its obligations under this Consulting Agreement; (ii) there are no other contracts, agreements, restrictive covenants or other restrictions preventing such party from
entering into this Consulting Agreement or performing its obligations hereunder; and (iii) the performance of its obligations pursuant to this Consulting Agreement shall comply with all applicable laws. 

8.2 Consultant represents, warrants and covenants that he is not, or during the Consulting Period will not become, the target of or
designated under any sanctions program that is established by statute or regulation of the United States, Order of the President of the United States or by designations of any department or agency of the United States government including

  
 3 

 
designations reflected in the “list of Specifically Designated Nationals and Blocked Persons” of the Office of Foreign Assets Control, U.S. Department of the Treasury or the Office of
Inspector General. If Consultant or any of its Representatives becomes the target or of designated under any such sanctions program during the Consulting Period, he/she shall immediately notify the Company thereof. 

8.2 Consultant represents and warrants that neither he nor any of his Representatives has been debarred pursuant to the Federal Food,
Drug and Cosmetic Act and is not currently excluded, debarred, suspended, or otherwise ineligible to participate in the federal health care programs or in federal procurement or non-procurement programs.
Moreover, if Consultant or any of its Representatives subsequently becomes debarred, excluded, suspended or ineligible as set forth in the preceding sentence, or is convicted of a criminal offense that falls within the scope of the federal statute
providing for mandatory exclusion from participation in federal health care programs but has not yet been excluded, debarred, suspended, or otherwise declared ineligible to participate in those programs, Consultant agrees to immediately notify the
Company of such event. Failure of Consultant to comply with this provision shall be a material breach of this Consulting Agreement warranting immediate termination. 

9. Arbitration and Equitable Relief. 

9.1 Arbitration. In consideration of Consultant’s rights under this Consulting Agreement, the Company’s promise to
arbitrate disputes under this Consulting Agreement, and the receipt of compensation paid to Consultant by the Company, at present and in the future, Consultant agrees that any and all controversies, claims, or disputes with anyone (including the
Company and any employee, officer, director, member or manager of the Company in its capacity as such or otherwise), whether brought on an individual, group, or class basis, arising out of, relating to, or resulting from Consultant’s providing
the Services under this Consulting Agreement or the termination of this Consulting Agreement, including any breach of this Consulting Agreement, shall be subject to binding arbitration. 

9.2 Procedure. Any arbitration will be administered by the American Arbitration Association (“AAA”), and the
neutral arbitrator will be selected in a manner consistent with AAA’s national rules for the resolution of business disputes. The arbitrator shall have the power to decide any motions brought by any party to the arbitration, including motions
for summary judgment and/or adjudication, motions to dismiss and demurrers, and motions for class certification, prior to any arbitration hearing. The arbitrator shall have the power to award any remedies available under applicable law, and the
arbitrator shall award attorneys’ fees and costs to the prevailing party except as prohibited by law. The Company and Consultant will each be responsible for their respective administrative and/or hearing fees charged by the arbitrator or the
AAA associated with any arbitration. The decision of the arbitrator shall be in writing. 
 9.3 Remedy. Except as provided by
the AAA rules and this Consulting Agreement, arbitration shall be the sole, exclusive and final remedy for any dispute between the Company and Consultant. Accordingly, except as provided for by said rules and this Consulting Agreement, neither the
Company nor Consultant will be permitted to pursue court action regarding claims that are subject to arbitration. The foregoing notwithstanding, the arbitrator will not have the authority to disregard or refuse to enforce any lawful Company policy,
and the arbitrator shall not order or require the Company to adopt a policy not otherwise required by law. 

  
 4 

 9.4 Availability of Injunctive Relief. Either the Company or Consultant may
petition a court for provisional relief, including injunctive relief, but not limited to, if either the Company or Consultant alleges or claims a violation of this Consulting Agreement between Consultant and the Company or any other agreement
regarding trade secrets, confidential information, and nonsolicitation. Consultant understands that any breach or threatened breach of such an agreement (including this Consulting Agreement) will cause irreparable injury and that money damages will
not provide an adequate remedy therefor and both Consultant and the Company hereby consent to the issuance of an injunction. 
 9.5
Voluntary Nature of Agreement. Consultant acknowledges that he/she is executing this Consulting Agreement voluntarily and without any duress or undue influence by the Company or anyone else. Consultant further acknowledges that he/she has
carefully read this Consulting Agreement and that he/she has asked any questions needed for it to understand the terms, consequences and binding effect of this Consulting Agreement and fully understands it. Finally, Consultant has been provided an
opportunity to seek the advice of an attorney of Consultant’s choice before signing this Consulting Agreement. 
 10. Miscellaneous. 

10.1 Governing Law; Interpretation. This Consulting Agreement shall be governed by the laws of the Commonwealth of Massachusetts
without regard to its conflicts of law rules. In the event of any dispute, this Consulting Agreement is intended by the parties to be construed as a whole, to be interpreted in accordance with its fair meaning, and not to be construed strictly for
or against either Consultant or the Company or the “drafter” of all or any portion of this Consulting Agreement. 
 10.2
Entire Agreement. This Consulting Agreement constitutes the entire agreement between the parties with respect to the subject matter of this Consulting Agreement and supersedes all prior written and oral agreements between the parties
regarding the subject matter of this Consulting Agreement. 
 10.3 Headings. Headings are used in this Consulting Agreement
for reference only and shall not be considered when interpreting this Consulting Agreement. 
 10.4 Notices. All notices,
consents, approvals, or other communications hereunder shall be in writing and shall be deemed given if delivered personally or sent by overnight courier service, or sent by facsimile or e-mail, promptly
confirmed by overnight courier service, addressed to the parties at the following addresses (or at such other address for a party as shall be specified by like notice, provided that notice of a change of address shall effective only upon receipt):

  

	 	(1)	 If to Consultant: 

David Hallal 
 139 Main St.,
Suite 500 
 Cambridge, MA 02142 

  
 5 

	 	(2)	 If to the Company, to: 

Allovir, Inc. 
 139 Main St.,
Suite 500 
 Cambridge, MA 02142 

Attn: General Counsel 
 Any
notice, consent, approval and other communication shall be deemed given, in the case of overnight courier service, on the next business day following its deposit with the courier, and, in the case of facsimile or
e-mail, upon transmission if confirmed by courier as set forth above. 
 10.5
Severability. If any provision in this Consulting Agreement shall be found or be held to be invalid or unenforceable in any jurisdiction in which this Consulting Agreement is being performed, then the meaning of said provision shall be
construed, to the extent feasible, so as to render the provision enforceable, and if no feasible interpretation would save such provision, it shall be severed from the remainder of this Consulting Agreement which shall remain in full force and
effect. In such event, the parties shall negotiate, in good faith, a substitute, valid and enforceable provision which most nearly effects the parties’ intent in entering into this Consulting Agreement. 

10.6 Counterparts. This Consulting Agreement may be executed simultaneously in two or more counterparts, each of which shall be
deemed an original, but all of which together shall constitute one and the same instrument. 
 10.7 Amendment; Waiver. This
Consulting Agreement may be amended by the parties hereto only by an instrument in writing signed on behalf of each of the parties hereto. No waiver of any term or condition of this Consulting Agreement shall be valid or binding on either party
unless the same shall be been mutually assented to in writing by both parties. The failure of either party to enforce at any time any of the provisions of this Consulting Agreement, or the failure to require at any time performance by the other
party of any of the provisions of this Consulting Agreement, shall in no way be construed to be a present or future waiver of such provisions, nor in any way affect the right of either party to enforce each and every such provision thereafter. The
express waiver by either party of any provision, condition or requirement of this Agreement shall not constitute a waiver of any future obligation to comply with such provision, condition or requirement 

10.8 Confidentiality. Neither party shall, at any time disclose to any third party the terms and conditions of this Consulting
Agreement except with the prior written consent of the other party, to their legal counsel or as required by law or regulation. This Section 10.8 shall survive the termination of this Consulting Agreement for any reason. 

  
 6 

 IN WITNESS WHEREOF, the parties hereto have executed this Consulting Agreement as of the
Effective Date. 
  

									
	CONSULTANT	 		 	COMPANY:
			
	 /s/ David Hallal
	 		 	 /s/ Diana Brainard

	By:	 	David Hallal	 		 	By: 	 	Diana Brainard
		 		 		 	Title:	 	Chief Executive Officer

  
 7 

 EXHIBIT A 

SERVICES, FEES, OTHER COMPENSATION AND EXPENSES 
  

	1.	 Services. 

Consultant will provide the following services during the Consulting Period (the “Services”). The Services to be provided by
Consultant include advising the Chief Executive Officer of the Company on certain strategic matters and to provide such other transitional and consulting services as reasonably requested by the Chief Executive Officer of the Company from time to
time. 
  

	2.	 Reimbursements. 

 

	 	A.	 Expenses. During the Consulting Period, the Company will reimburse Consultant for all reasonable and
actual business expenses incurred by Consultant in providing the Services pursuant to this Consulting Agreement (“Reimbursements”). Reimbursements are subject to Consultant’s timely submission of receipts in accordance with Company
policies and within thirty (30) days following the date such expenses are incurred. 

 Any Reimbursements in excess of
$250.00 per month shall require pre-approval from Consultant’s principal Company contact. The Company’s payment of any Reimbursements will be made within thirty (30) days following
Consultant’s submission of a proper reimbursement request. 
  

	 	B.	 Travel Expenses. During the Consulting Period, the Company will reimburse Consultant for all reasonable
and actual business travel expenses (air/ground) for travel to/from the Company site or other designated site. 

 INITIALS: 

 

							
	  
	  	 July 22, 2021
	  	  
	  	 July 22, 2021

	CONSULTANT	  	Date	  	COMPANY	  	Date

  
 1 

 EXHIBIT B 

PROPRIETARY INFORMATION AND INVENTION ASSIGNMENT AGREEMENT 

PROPRIETARY INFORMATION 

AND INVENTION ASSIGNMENT AGREEMENT 

As a condition of Consultant’s engagement (with the term “engagement” or any derivation such as
“engage,” as used herein, to include any consulting or independent contractor relationship) in any capacity with AlloVir, Inc., its subsidiaries, affiliates, successors or assigns (together the “Company”), and in
consideration of Consultant’s engagement in any capacity with the Company and Consultant’s receipt of the compensation now and hereafter paid to Consultant by the Company, Consultant will execute this Proprietary Information and Invention
Assignment Agreement (this “Agreement”), and agrees to the following: 
 1. Proprietary Information. 

(a) Company Information. Consultant agrees at all times during the term of Consultant’s engagement and thereafter, to hold
in strictest confidence, and not to use, except for the benefit of the Company, or to disclose to any person, firm or corporation without written authorization of the Board of Directors of the Company, any Proprietary Information of the Company,
except under a non-disclosure agreement duly authorized and executed by the Company. Consultant understands that “Proprietary Information” means any non-public
information regarding or relating to the Company or its products including: (1) the actual or anticipated business or research and development of the Company, technical data, trade secrets or know-how,
including, but not limited to, research, product plans or other information regarding the Company’s products or services and markets therefore; (2) research, clinical or other trials, developments, inventions, processes, formulas,
technology, designs, drawings, engineering, software, hardware configuration information, marketing, finances or other business information; (3) customer lists and customers (including, but not limited to, customers of the Company on whom
Consultant called or with whom Consultant became acquainted during the term of Consultant’s engagement); (4) the identity, skills and compensation of employees, consultants, or contractors; (5) policies and procedures of the Company;
(6) anything related to Company Inventions (as defined herein); and (7) Third Party Information (as defined herein). Consultant further understands that Proprietary Information does not include any of the foregoing items which have become
publicly known and made generally available through no wrongful act of the Consultant or of others who were under confidentiality obligations as to the item or items involved or improvements or new versions thereof. Notwithstanding the
foregoing, pursuant to 18 U.S.C. Section 1833(b), Consultant shall not be held criminally or civilly liable under any Federal or State trade secret law for the disclosure of a trade secret that: (1) is made in confidence to a Federal,
State, or local government official, either directly or indirectly, or to an attorney, and solely for the purpose of reporting or investigating a suspected violation of law; or (2) is made in a complaint or other document filed in a lawsuit or
other proceeding, if such filing is made under seal. In addition, notwithstanding the foregoing, Consultant shall not be prohibited from disclosing Proprietary Information to a government agency as a whistleblower. 

  
 2 

 (b) Third Party Information. Consultant recognizes that the Company has
received and, in the future, will receive from third parties their confidential or proprietary information subject to a duty on the Company’s part to maintain the confidentiality of such information and to use it only for certain limited
purposes (“Third Party Information”). Consultant agrees to hold all Third-Party Information in the strictest confidence and not to disclose it to any person, firm or corporation or to use it except as necessary in carrying out
Consultant’s work for the Company consistent with the Company’s agreement with such third party. 
 2. Inventions. 

(a) Inventions Retained and Licensed. Consultant has attached hereto, as Exhibit 1, a list describing all inventions, original
works of authorship, developments, improvements, and trade secrets which were made by Consultant prior to Consultant’s engagement with the Company (collectively referred to as “Prior Inventions”), which belong to Consultant, which
relate to the Company’s proposed business, products or research and development, and which are not assigned to the Company hereunder; or, if no such list is attached, Consultant represents that there are no such Prior Inventions. If in the
course of Consultant’s engagement with the Company, Consultant incorporates into a Company product, process or service a Prior Invention owned by Consultant or in which Consultant has an interest, Consultant hereby grants to the Company a
nonexclusive, royalty-free, fully paid-up, irrevocable, perpetual, worldwide license to make, have made, modify, use and sell such Prior Invention as part of or in connection with such product, process or
service, and to practice any method related thereto. 
 (b) Assignment of Inventions. Consultant agrees that Consultant will
promptly make full written disclosure to the Company, will hold in trust for the sole right and benefit of the Company, and hereby assign (or, for future inventions, agree to assign) to the Company, or its designee, all Consultant’s right,
title, and interest in and to any and all inventions, original works of authorship, writings, developments, concepts, improvements, designs, discoveries, ideas, processes, formulas, data, trademarks or trade secrets, whether or not patentable or
registrable under copyright or similar laws, which Consultant may solely or jointly conceive or develop or reduce to practice within the scope of Consultant’s engagement, or cause to be conceived or developed or reduced to practice, during the
period of time Consultant is engaged by the Company (collectively referred to as “Inventions”), except as provided in Section 3(f) below. Consultant agrees that Company will exclusively own all work product that is made by
Consultant (solely or jointly with others) within the scope of Consultant’s engagement. Consultant further acknowledges that all original works of authorship which are made by Consultant (solely or jointly with others) within the scope of and
during the period of Consultant’s engagement with the Company and which are protectable by copyright are “works made for hire,” as that term is defined in the United States Copyright Act. Consultant understands and agrees that the
decision whether or not to commercialize or market any Invention developed by Consultant solely or jointly with others is within the Company’s sole discretion and for the Company’s sole benefit and that no royalty will be due to Consultant
as a result of the Company’s efforts to commercialize or market any such Invention. Consultant acknowledges and agrees that nothing in this Agreement shall be deemed to grant, by implication, estoppel or otherwise, a license from the Company to
me to make, use, license, or transfer in any way an existing or future Invention. 

  
 3 

 (c) Inventions Assigned to the United States. Consultant agrees to assign to
the United States government all Consultant’s right, title, and interest in and to any and all Inventions whenever such full title is required to be in the United States by a contract between the Company and the United States or any of its
agencies. 
 (d) Maintenance of Records. Consultant agrees to keep and maintain adequate and current written records of all
Inventions made by Consultant (solely or jointly with others) during the term of Consultant’s engagement with the Company. The records will be in the form of notes, sketches, drawings, and any other format that may be specified by the Company.
The records will be available to and remain the sole property of the Company at all times. 
 (e) Patent and Copyright
Registrations. Consultant agrees to assist the Company, or its designee, at the Company’s expense, in every proper way to secure the Company’s rights in the Inventions and any copyrights, patents, mask work rights or other
intellectual property rights relating thereto in any and all countries, including the disclosure to the Company of all pertinent information and data with respect thereto, the execution of all applications, specifications, oaths, assignments and all
other instruments which the Company shall deem necessary in order to apply for and obtain such rights and in order to assign and convey to the Company, its successors, assigns, and nominees the sole and exclusive rights, title and interest in and to
such Inventions, and any copyrights, patents, mask work rights or other intellectual property rights relating thereto. Consultant further agrees that Consultant’s obligation to execute or cause to be executed, when it is in Consultant’s
power to do so, any such instrument or papers shall continue after the termination of this Agreement. If the Company is unable because of Consultant’s mental or physical incapacity or for any other reason to secure Consultant’s signature
to apply for or to pursue any application for any United States or foreign patents or copyright registrations covering Inventions or original works of authorship assigned to the Company as above, then Consultant hereby irrevocably designates and
appoints the Company and its duly authorized officers and agents as Consultant’s agent and attorney in fact, to act for and in Consultant’s behalf and stead to execute and file any such applications and to do all other lawfully permitted
acts to further the prosecution and issuance of letters patent or copyright registrations thereon with the same legal force and effect as if executed by Consultant. 

3. Former Employer Information. Consultant agrees that Consultant will not, during Consultant’s engagement with the Company,
improperly use or disclose any proprietary information or trade secrets of any former or concurrent employer or other person or entity and that Consultant will not bring onto the premises of the Company any unpublished document or proprietary
information belonging to any such employer, person or entity unless consented to in writing by such employer, person or entity. Consultant further agrees that Consultant will not incorporate into any Invention any Proprietary Information or trade
secrets of any former employer or other person or entity. 
 4. Conflicting Employment. Subject to the forgoing, Consultant agrees
that, during the term of Consultant’s engagement with the Company, Consultant will not engage in any other engagement, occupation or consulting directly related to any business in which the Company is now involved or becomes involved during the
term of Consultant’s engagement, nor will Consultant engage in any other activities that conflict with Consultant’s obligations to the Company. 

  
 4 

 5. Returning Company Documents. Consultant agrees that, at the time of leaving the
Company, Consultant will promptly deliver to the Company (and will not keep on a computer or otherwise in Consultant’s possession, recreate or deliver to anyone else) any and all documents, records, data, notes, reports, proposals, lists,
correspondence, specifications, drawings, blueprints, sketches, materials, devices, equipment, other property, or reproductions of any aforementioned items developed by Consultant pursuant to Consultant’s engagement with the Company or
otherwise belonging to the Company, its successors or assigns, including, without limitation, those records maintained pursuant to paragraph 2(d). 
 6.
Non-Solicitation. 
 (a) Solicitation of Employees. Consultant
agrees that for a period of one (1) year immediately after Consultant’s engagement with the Company is terminated, for any reason, whether with or without cause and whether voluntarily or involuntarily, Consultant shall not, directly or
indirectly, solicit, induce, recruit or encourage any of the Company’s then current employees to leave their engagement, or take away such employees, or attempt to solicit, induce, recruit, encourage or take away employees of the Company,
either for Consultant or for any other person or entity. 
 (b) Solicitation of Customers. Consultant agrees that for a
period of one (1) year immediately after Consultant’s engagement with the Company is terminated for any reason, whether with or without cause and voluntarily or involuntarily, Consultant shall not, directly or indirectly, on behalf of any
other person, firm, partnership, corporation, or business entity of any type, solicit for the benefit of any competitor of the Company, take away or attempt to take away, in whole or in part, any Customer of the Company or otherwise interfere with
the Company’s relationship with any Customer. For purposes of this Section 6, “Customer” shall mean any company or business entity to which the Company sells or licenses goods or services to or that Consultant had contact with or
performed services for during Consultant’s engagement with the Company. 
 (c) Solicitation of Business Partners.
Consultant agrees that for a period of one (1) year immediately after Consultant engagement with the Company is terminated for any reason, whether with or without cause and voluntarily or involuntarily, Consultant shall not, without the
express written consent of the Company, directly or indirectly contract with, license to or from, or do any business with a Business Partner of the Company in any manner that would (i) involve any Business or (ii) take away or attempt to
take away, in whole or in part, any Business Partner of the Company or otherwise interfere with the Company’s relationship with any Business Partner. As used herein, a “Business Partner” is any third party with whom the Company has
entered into a relationship or with whom the Company is actively engaged in discussions related to a potential relationship at any time during the term of Consultant’s engagement. 

7. Representations. Consultant agrees to execute any proper oath or verify any proper document required to carry out the terms of this
Agreement. Consultant represents that Consultant’s performance of all the terms of this Agreement will not breach any agreement to keep in confidence proprietary information acquired by Consultant in confidence or in trust prior to
Consultant’s engagement by the Company. Consultant hereby represents and warrants that Consultant has not entered into, and Consultant will not enter into, any oral or written agreement in conflict herewith. 

  
 5 

 8. General Provisions. 

(a) Governing Law; Consent to Personal Jurisdiction. This Agreement will be governed by the laws of the State of Texas.
Consultant hereby expressly consents to the personal jurisdiction of the state and federal courts located in Texas for any lawsuit filed there against Consultant by the Company arising from or relating to this Agreement, and Consultant agrees that
the exclusive forum for any dispute shall be courts in the State of Texas. 
 (b) Entire Agreement. This Agreement, along with
any application Consultant has submitted to the Company, if any, and any executed Consulting Agreement Consultant has with the Company, if any, sets forth the entire agreement and understanding between the Company and Consultant relating to the
subject matter herein and supersedes all prior discussions or representations between us including, but not limited to, any representations made during Consultant’s interview(s), whether written or oral. No modification of or amendment to this
Agreement, nor any waiver of any rights under this Agreement, will be effective unless in writing signed by the President of the Company and Consultant. Any subsequent change or changes in Consultant ‘s duties, or compensation will not affect
the validity or scope of this Agreement. 
 (c) Severability. If one or more of the provisions in this Agreement are deemed
void by law, then the remaining provisions will continue in full force and effect. 
 (d) Successors and Assigns. This
Agreement will be binding upon Consultant’s heirs, executors, administrators and other legal representatives and will be for the benefit of the Company, its successors, and its assigns. 

(e) Notices. Any notices required or permitted hereunder shall be given to the appropriate party at the party’s last known
address. Such notice shall be deemed given upon personal delivery to the last known address or if sent by certified or registered mail, three days after the date of mailing. 

(f) Survival. The provisions of this Agreement shall survive the termination of Consultant’s engagement for any reason and
assignment of this Agreement by the Company to any successor in interest or other assignee. 
 (g) Headings. The headings to
each section or paragraph of this Agreement are provided for convenience of reference only and shall have no legal effect in the interpretation of the terms hereof. 

Consultant has read this Proprietary Information, And Invention Assignment Agreement and understand its terms. Consultant has
completely filled out Exhibit 1 to this Agreement relating to Prior Inventions. 
 This agreement shall be effective as of the first day of
Consultant’s engagement, which will begin on: July     , 2021. 

  
 6 

 Consultant understands that this agreement affects Consultant’s rights to Inventions
that Consultant makes during Consultant’s engagement with the Company, restricts Consultant’s rights to disclose or use Proprietary Information and Third Party Information or subsequent to Consultant’s period of engagement, and
prohibits Consultant from competing with the Company and from soliciting Company employees and Business Partners for one year after Consultant’s engagement is terminated for any reason. 

Consultant is executing this Agreement voluntarily. 
  

			
	Signature:	 	  

			
		
	Print Name:	 	David Hallal

			
	Date:	 	July 22, 2021

 ACCEPTED AND AGREED TO: 

AlloVir, Inc. 
  

			
	Signature:	 	  

			
	Print Name:	 	Diana Brainard

			
	Title:	 	Chief Executive Officer
	Date:	 	July 22, 2021

 Signature Page for the 

Proprietary Information and Invention Assignment Agreement 

  
 7 

 Exhibit 1 

LIST OF PRIOR INVENTIONS 

AND ORIGINAL WORKS OF AUTHORSHIP 
  

	
	Title:                                   
                                     
	
	Date:                                     
                                   

 Identifying Number or Brief Description 
  

	
	  

	
	  

	
	  

     No inventions or improvements 

      Additional Sheets Attached 
  

			
	Signature of Consultant or Independent Contractor:	 	  

 

			
	Print Name of Consultant or Independent Contractor:	 	

  

	
	Date:                                     
                                   

  
 8

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00331-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00331-of-00352.parquet"}]]